| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| SAB Biotherapeutics, Inc. | Director | Stock Option (right to buy) | 20,000 | 15 Jul 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SABS | SAB Biotherapeutics, Inc. | 15 Jul 2024 | 1 | $0 | 4 | Director | 17 Jul 2024, 16:30 |
| SABS | SAB Biotherapeutics, Inc. | 28 Feb 2023 | 1 | $0 | 4 | Director | 02 Mar 2023, 08:20 |
| SABS | SAB Biotherapeutics, Inc. | 07 Dec 2022 | 2 | +$99,999 | 4 | Director | 09 Dec 2022, 08:02 |
| SABS | SAB Biotherapeutics, Inc. | 20 May 2022 | 1 | $0 | 4 | Director | 23 May 2022, 17:52 |
| SABS | Big Cypress Acquisition Corp. | 01 Oct 2021 | 1 | +$130,910 | 4 | Director | 05 Oct 2021, 17:00 |